SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148592

Cover Image

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148592

Influenza Medication

PUBLISHED:
PAGES: 286 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Team License: Up to 10 users)
USD 11115
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Influenza Medication Market to Reach US$1.6 Billion by 2032

The global market for Influenza Medication estimated at US$1.0 Billion in the year 2025, is expected to reach US$1.6 Billion by 2032, growing at a CAGR of 6.5% over the analysis period 2025-2032. Vaccines Type, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$655.3 Million by the end of the analysis period. Growth in the Antiviral Drugs Type segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$281.5 Million While China is Forecast to Grow at 10.3% CAGR

The Influenza Medication market in the U.S. is estimated at US$281.5 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$343.7 Million by the year 2032 trailing a CAGR of 10.3% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Influenza Medication Market - Key Trends & Drivers Summarized

Why Is the Demand for Influenza Medication Rising?

The influenza medication market is witnessing a surge in demand due to the recurrent nature of influenza and its significant health impact globally. Seasonal flu outbreaks, alongside pandemic potential strains, create a continuous need for effective antiviral treatments. Influenza medications, such as neuraminidase inhibitors and antiviral drugs, play a crucial role in reducing symptoms and shortening illness duration, thus lowering the strain on healthcare systems during peak flu seasons. With influenza remaining a major public health challenge, particularly among vulnerable populations such as the elderly and immunocompromised, the demand for both prescription and over-the-counter flu medications remains high.

How Are New Therapeutic Approaches Influencing the Market?

Pharmaceutical advancements are leading to the development of new antiviral drugs and therapies that are more effective against evolving influenza strains. The introduction of antiviral treatments with broader spectrums, such as baloxavir marboxil, has expanded options for early and efficient influenza treatment. Furthermore, research into combination therapies is showing promise in combating drug-resistant strains and improving treatment outcomes. Innovations in drug delivery, such as inhalable antivirals and fast-dissolving tablets, are also enhancing patient adherence and providing easier access to treatment. These advances are contributing to a more diverse and responsive influenza medication market.

What Role Do Preventive Strategies Play in Influenza Medication Demand?

Preventive strategies, including vaccination and public health campaigns, play a pivotal role in managing influenza spread but do not eliminate the need for antiviral medications. Seasonal vaccines may not fully cover all strains due to mutation rates, leaving a gap in immunity that medications can address. Additionally, antiviral medications are recommended for high-risk groups and individuals with severe symptoms even with vaccination. Consequently, demand for influenza medications remains high, as they serve as a critical line of defense in managing outbreaks and providing symptomatic relief, particularly when vaccine efficacy varies or is unavailable.

The Growth in the Influenza Medication Market Is Driven by Several Factors

The growth in the influenza medication market is driven by several factors, including the persistent threat of seasonal flu, development of innovative antiviral drugs, and demand for faster-acting treatments. The rising incidence of flu cases each year ensures continuous demand for effective medications, especially in high-risk populations. The emergence of new antiviral treatments with fewer side effects and more targeted efficacy is appealing to healthcare providers. Additionally, the need for swift and accessible treatments during peak flu seasons and in pandemic situations has prompted increased investment in drug research and development. These factors collectively support the sustained expansion of the influenza medication market.

SCOPE OF STUDY:

The report analyzes the Influenza Medication market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Vaccines Type, Antiviral Drugs Type, Antihistamines Type, Other Types); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Amneal Pharmaceuticals, LLC
  • Beijing Biostar Pharmaceuticals Co., Ltd.
  • Daiichi Sankyo Co., Ltd.
  • F. Hoffmann-La Roche AG
  • GSK Plc
  • Macleods Pharmaceuticals Ltd.
  • Natco Pharma Limited
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Show more
Product Code: MG16504

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Influenza Medication - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 46 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Awareness of Seasonal Flu Prevention and Treatment
    • Rising Demand for Over-the-counter Influenza Medications
    • Expansion of Vaccination Programs Boosting Antiviral Sales
    • Growth in Demand for Rapid Diagnostic Testing and Treatment Solutions
    • Development of Novel Antiviral Drugs for Drug-resistant Influenza Strains
    • Increased Focus on Combination Therapies for Enhanced Efficacy
    • Rising Investment in R&D for Long-acting Influenza Drugs
    • Surge in Stockpiling of Antiviral Drugs for Pandemic Preparedness
    • Growth in Demand for Pediatric and Geriatric Flu Medications
    • Enhanced Focus on Symptom-relief Products in OTC Market
    • Demand for Easy-to-administer and Fast-acting Treatments
    • Expansion in Online Pharmacies for Accessible Influenza Medication
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Influenza Medication Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Influenza Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Influenza Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Influenza Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Vaccines Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Vaccines Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Vaccines Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Antiviral Drugs Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Antiviral Drugs Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Antiviral Drugs Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Antihistamines Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Antihistamines Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Antihistamines Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 28: USA 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 29: USA Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 30: USA Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 31: USA 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Canada Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 36: Canada Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 37: Canada 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • JAPAN
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Japan Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 42: Japan Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 43: Japan 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • CHINA
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 45: China Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 46: China 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 47: China Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 48: China Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 49: China 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • EUROPE
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Europe Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Influenza Medication by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 54: Europe Historic Review for Influenza Medication by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for Influenza Medication by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Europe Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 58: Europe 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • FRANCE
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 60: France Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 61: France 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 62: France Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 63: France Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 64: France 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • GERMANY
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Germany Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Germany Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 70: Germany 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Italy Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Italy Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 76: Italy 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 78: UK Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 79: UK 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 80: UK Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 81: UK Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 82: UK 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Spain Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 85: Spain 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Spain Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 88: Spain 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Russia Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 91: Russia 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Russia Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 94: Russia 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 97: Rest of Europe 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 100: Rest of Europe 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Medication by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Influenza Medication by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 103: Asia-Pacific 13-Year Perspective for Influenza Medication by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 106: Asia-Pacific 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 109: Asia-Pacific 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Australia Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 112: Australia 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Australia Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 115: Australia 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • INDIA
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 117: India Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 118: India 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 119: India Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 120: India Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 121: India 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 123: South Korea Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 124: South Korea 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 126: South Korea Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 127: South Korea 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Latin America Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 136: Latin America 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Influenza Medication by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 138: Latin America Historic Review for Influenza Medication by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 139: Latin America 13-Year Perspective for Influenza Medication by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Latin America Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 142: Latin America 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 144: Argentina Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 145: Argentina 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Argentina Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 148: Argentina 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Brazil Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 151: Brazil 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Brazil Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 154: Brazil 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Mexico Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 157: Mexico 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Mexico Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 160: Mexico 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 163: Rest of Latin America 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 166: Rest of Latin America 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Middle East Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 169: Middle East 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Influenza Medication by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 171: Middle East Historic Review for Influenza Medication by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 172: Middle East 13-Year Perspective for Influenza Medication by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Middle East Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 175: Middle East 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Iran Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 178: Iran 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Iran Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 181: Iran 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Israel Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 184: Israel 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Israel Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 187: Israel 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 190: Saudi Arabia 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 193: Saudi Arabia 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 195: UAE Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 196: UAE 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 198: UAE Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 199: UAE 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 202: Rest of Middle East 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 205: Rest of Middle East 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032
  • AFRICA
    • Influenza Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Africa Historic Review for Influenza Medication by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 208: Africa 13-Year Perspective for Influenza Medication by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Africa Historic Review for Influenza Medication by Type - Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 211: Africa 13-Year Perspective for Influenza Medication by Type - Percentage Breakdown of Value Sales for Vaccines Type, Antiviral Drugs Type, Antihistamines Type and Other Types for the Years 2020, 2026 & 2032

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!